Lv5
1206 积分 2025-05-29 加入
Clinical pathological expert consensus on HER2 immunohistochemical testing in urothelial carcinoma(2026 version)
1个月前
已完结
Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study
2个月前
已完结
Efficacy and safety of MRG002 monotherapy in treating patients with locally advanced or metastatic breast cancer with low HER2 expression: A multi-center, non-randomized, open-label phase II clinical trial
2个月前
已完结
Performance of HER2 DAKO HercepTest and Ventana 4B5 immunohistochemical assays on detecting HER2 gene-amplification in uterine serous carcinomas
2个月前
已完结
Guidelines on tests of PIK3CA mutation in breast cancer in China (2025 version)
2个月前
已完结
实体瘤常见驱动基因DNA和RNA高通量测序共检专家共识（2025版）
2个月前
已完结
Prognostic value of circulating HER2 extracellular domain in patients with HER2-positive metastatic breast carcinoma treated with TDM-1 (trastuzumab emtansine)
5个月前
已完结
DLBclass: a probabilistic molecular classifier to guide clinical investigation and practice in diffuse large B-cell lymphoma
5个月前
已关闭
DLBclass: a probabilistic molecular classifier to guide clinical investigation and practice in diffuse large B-cell lymphoma
5个月前
已完结
Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
6个月前
已完结
皖公网安备34019202002308
